October 19, 2022 from 1:00-2:30 PM EDT
This webinar program will review the core principles of objective product evaluation for infection prevention and control products utilized in healthcare. This webinar will introduce an evidence-based product evaluation framework from the Centers for Disease Control and Prevention to assist value analysis and clinical professionals in confidently evaluating any new product technology.
Q & A Objectives:
- Discuss the impact of Infection Prevention and Control on value analysis in a postpandemic healthcare environment
- Review the steps in the Value Analysis process necessary to ensure optimal patient outcomes and reduced risks for the healthcare system
- Discuss the need for collaboration between Infection Prevention and Control and Value Analysis to improve the delivery of clinical care
Continuing Education Accreditation Statement:
Terri Goodman & Associates is approved as a provider of nursing continuing professional development by the California Board of Nursing. Certificate of Completion available to all live webinar participants. This activity is approved for 1.5 contact hours and requires that attendees attend at least 90% of the entire activity in order to be eligible for contact hours.
Hudson Garrett Jr., PhD, MSN, MPH, MBA, FNP-BC, IP-BC, PLNC, CFER, AS-BC, VA-BC, BC-MSLcert™, NREMT, MSL-BC, DICO-C, TR-C, CPPS, CCHR-S, CPHQ, CPXP, FACDONA, FAAPM, FNAP, FSHEA, FIDSA
Adjunct Assistant Professor of Medicine
Division of Infectious Diseases, Department of Medicine
University of Louisville School of Medicine
President and Chief Executive Officer
Community Health Associates, LLC
Dr. Hudson Garrett is an Adjunct Assistant Professor of Medicine in the Division of Infectious Diseases at the University of Louisville School of Medicine and a Faculty member for the newly created Center for Education and Training Infection Prevention which is a CDC-funded training center. He also co-founded the nonprofit the Infection Prevention Institute to help shepherd dissemination of best practices of infection prevention and control across the healthcare continuum of care globally. He holds a Graduate Certificate in Infection Prevention and Infection Control from the University of South Florida. He has completed the Johns Hopkins Fellows Program in Hospital Epidemiology and Infection Control. He is also a Fellow in the Academy of National Associations of Directors of Nursing Administration and was selected as a Lifetime Member in the Association, which is the highest honor bestowed upon a member. He is also a Fellow, the American Academy of Project Management, and a Senior Fellow and Ambassador of the Management and Strategy Institute. In 2019, he was inducted as a Distinguished Fellow and Practitioner in the National Academies of Practices. Dr. Garrett was recently selected in 2020 as 1 of 20 healthcare leaders globally to participate in the 2021 13-month Global Patient Safety Fellowship with the Institute for Healthcare Improvement and is a graduate of the IHI Patient Safety Executive Development Program. In August of 2021, Dr. Garrett was awarded the prestigious Fellowship Designation by the Society for Healthcare Epidemiology of America in recognition of his work in infectious diseases and infection prevention and control. In November 2021, he was awarded the Fellow Designation by the Infectious Diseases Society of America. He holds graduate certificates in healthcare leadership from both Cornell and the University of Notre Dame. He is an appointed member of the advisory committee for the Design Thinking in Healthcare Program at Rutgers University. He is a frequent international lecturer in the areas of infectious diseases, healthcare-associated infections, outbreak response and prevention and infection prevention and control. He has testified to the Centers for Disease Control and Prevention, Environmental Protection Agency, and Food and Drug Administration.